1 / 19

Acetaminophen Associated Hypotension

Acetaminophen Associated Hypotension. Presenter: Ri 林志銘 11.20. Introduction (1). Acetaminophen Analgesic-Antipyretic Most commonly used drugs Mechanism Central nervous system Weak cyclooxygenase inhibitor Inhibition of prostaglandin synthesis Dosage (Adult)

tekli
Download Presentation

Acetaminophen Associated Hypotension

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Acetaminophen Associated Hypotension Presenter: Ri 林志銘 11.20

  2. Introduction (1) • Acetaminophen • Analgesic-Antipyretic • Most commonly used drugs • Mechanism • Central nervous system • Weak cyclooxygenase inhibitor • Inhibition of prostaglandin synthesis • Dosage (Adult) • 650~1000 mg PO Q4h, max 4 g/day • 650 mg reatally Q4~6h, max 6 supp./day

  3. Introduction (2) • Acetaminophen • Pharmacokinetics • Onset: 0.5 hour • Duration: 4 hours • Metabolism • Liver, first pass 25 % • Metabolite: • Glucuronic acid conjugate • Sulfate conjugate • Excretion: kidney • Contraindication • Hypersensitivity

  4. Introduction (3) • Acetaminophen • Common adverse reaction • Hypertension • Addition to an anti-hypertensive regimen • Renal vasodilators (Prostaglandins) were inhibited by cyclooxygenase • Primarily prostaglandins E2, I2, and F2a. • Vasoconstriction -> ↑systemic BP 5 mm Hg • Risk group • Women who took more than 500 mg/day • Hypertensive patients

  5. Introduction (4) • Acetaminophen • Common adverse reaction • Acute hepatotoxicity • Allergic reactions • Drug eruption, difficulty breathing • Abdominal pain • Nausea • Unusual bleeding or bruising

  6. Hypotension Following Acetaminophen Administration (1) • Mackenzie et al (1999) • Retrospective control study • Topic: • To find associations between AAP administration and Hypotension • Subjects: • 53 patients in ICU stay(29/11/1997~ 29/1/1999) • 191 episodes AAP administration (500 mg PO/rectal)) • Methods: • Chart review • Record T/MAP/HR from 2 hours before administration to 3 hours after • Excluded repeat administrations in recent 6 hours

  7. Hypotension Following Acetaminophen Administration (2) • Mackenzie et al (1999) • Comparisons • Baselines: • MAP/HR- 2 hours preceding administration • T- 6 hours preceding administration • Experimental group: • T/MAP/HR in +1,+2, +3 hour • Control group: • The same patient in • 24 hour prior/after administration • 8 hour prior/after administration

  8. Hypotension Following Acetaminophen Administration (3) • Mackenzie et al (1999) • Results: • Compared to baseline • Significant fall in T/MAP/HR at +1, +2, +3 hour (p< 0.0001) except HR at +1 • Lowest MAP: 89.0% (48.8~113.3 %), male greater than female (87.1 vs 94.6%) • Compared to control • Significant fall in T/MAP/HR at +1, +2, +3 hour (p< 0.0005) except HR at +1 • Correlation between post-AAP hypotension • Age (p=0.04) • Baseline MAP (p=0.02) Crit Care Med Vol 27 (12) Supp A33

  9. Effects of AAP administration • Mackenzie et al (2000) Intensive Care Med 26: 1408

  10. Similar study • Boyle M et al (1997) • Prospective observational cohort study • 27 subjects (23 with fever, 12 with vasoactive infusions, 7 with regular anti-hypertensive drugs) • Record SBP/DBP/MAP in all patients taking acetaminophen 1 gm orally • 30 mins prior • 15 mins interval for the first hour • 30 mins interval for the second hour • Results • SBP • Fall significantly in all observation times • 133(4.7) mmHg in -30 mins -> 116(3.8) mmHg in +45 mins • Max fall in 30 mins 36 % • MAP • Fall significantly in 30, 45, 60, 90 mins after AAP administration • 84(2.9) mmHg in -30 mins -> 78(2.5) mmHg in +45 mins • Max fall 34 % in 30/45 mins Aust Crit Care 199710:120-122

  11. Case report • Brown G (1996) • #1 53 y/o female • Short of breath , • CXR: RLL, LLL consolidation • Admitted to ICU • Intubation for inadequate arterial oxygenation • APP administration were associated with changes in BP • Increased requirements of vasopressors use • Day 3~8 hypotension with vasopressors use • Erythematous rash rash on the back • DC APP → no further episodes of hypotension Heart & Lung 25 (2); 137~140

  12. Case report • Brown G (1996) • #2 21 y/o male • Admitted for Chemotherapy of amyeloblastic leukemia • Day 1~6 cytarabine 1.5 gm/m2 • Day 7~9 daunorubicin • Day 17~22 neutropenic fever • Use gentamycin/ ceftazidine /vancomycin / amphotericin B • Day 23 transfer to ICU • Short of breath, resp. failure,intubation for mechanical support • During ICU course • AAP was administered as an anti-pyretic in an attempt to reduce oxygen demand • The major changes in blood pressure were associated with AAP administration Heart & Lung 25 (2); 137~140

  13. Possible Hypothesis • Hypotension could be • Due to acetaminophen related or in acute phase of septic shock or SIRS • Need RCT evidence • APP administration in afebrile condition • Part of delayed hypersensitivity or anaphylactoid reaction • Other unknown mechanism

  14. Acetaminophen Hypersensitivity • Vidal et al (1997) • Aspirin and other NSAID may induce urticaria, angioedema, rhinitis, bronchial athma and anaphylactoid reaction • Acetaminophen intolerance can occur less than 5 % of aspirin-sensitive subject • Hypersensitivity to acetaminophen without aspirin sensitivity is rare. • Oral provocation test, specific IgE antibodies • Case report: • 40 y/o female, hypotension (70/40 mmHg), generalized hives • A real allergic mechanism rather than inhibition of prostglandin synthesis Ann Allergy Asthma Immunol 79:320-321

  15. Anaphylactoid reaction to AAP • Ayonrinde OT, and Saker BM (2000) • Adverse reaction to AAP, even in therapeutic range can have near fatal consquences Postgrad Med J 2000; 76:501~502

  16. Conclusions • Anaphylaxis or anaphylactoid reaction could be one reason of the APP associated hemodynamic change. • Only extremely rarely does AAP result in hypotension. • Further randomized, placebo-controlled trials are necessary to recognize AAP, temperature and SIRS relationships. • Clinician should be vigilant in hypotensive episodes follow administration of AAP • Fluid and vasopressor would be treatment of choice. • Should be mentioned in product information

  17. Thanks for your attention !!

More Related